Complete Filing Data
Alpha Cognition Inc. reported Stockholders Equity of $62.53 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Alpha Cognition Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income Loss | -$20.7M | -$14.8M | -$13.8M |
| Research And Development Expense | $1.9M | $3.9M | $4.9M |
| Operating Income Loss | -$22.7M | -$12.0M | -$9.9M |
| Nonoperating Income Expense | $2.0M | -$2.8M | -$3.8M |
| Interest Expense Nonoperating | $105.3K | $17.5K | |
| Operating Expenses | $11.9M | $9.9M | |
| General And Administrative Expense | $7.9M | $5.1M | |
| Comprehensive Income Net Of Tax | -$14.6M | -$13.8M | |
| Government Assistance Nonoperating Income | $81.1K | $463.9K | $260.5K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$19.6K | ||
| Impairment Of Intangible Assets Finitelived | $39.2K | ||
| Selling General And Administrative Expense | $29.1M | $8.0M | |
| Revenues | $10.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$1.3M | -$10.5M | -$2.0M | -$1.9M | -$2.1M | -$5.0M | -$3.3M | -$2.8M | |
| Research And Development Expense | $573.6K | $317.1K | $407.5K | $996.0K | $967.2K | $916.7K | $1.4M | $1.2M | |
| Operating Income Loss | -$5.3M | -$5.7M | -$3.7M | -$2.5M | -$2.4M | -$4.4M | -$2.8M | -$2.7M | |
| Nonoperating Income Expense | $4.0M | -$4.8M | $1.7M | $627.9K | $305.7K | -$591.2K | -$503.2K | -$89.5K | |
| Interest Expense Nonoperating | -$644.00 | $8.8K | $18.7K | $15.2K | $8.3K | $9.6K | $1.5K | ||
| Operating Expenses | $2.5M | $2.4M | $2.8M | $2.7M | |||||
| General And Administrative Expense | $1.5M | $1.5M | $1.3M | $1.5M | |||||
| Comprehensive Income Net Of Tax | -$1.9M | -$2.1M | -$3.3M | -$2.8M | |||||
| Government Assistance Nonoperating Income | $10.0K | $71.1K | $61.1K | $138.6K | $133.8K | $32.8K | |||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$11.2K | $27.9K | |||||||
| Impairment Of Intangible Assets Finitelived | $39.2K | ||||||||
| Selling General And Administrative Expense | $6.9M | $6.5M | $5.4M | $1.5M | $1.4M | $3.5M | |||
| Revenues | $2.8M | $1.7M | $2.9M | $100.0M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | $62.5M | $39.1M | -$4.7M | -$1.3M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $66.1M | $48.6M | $1.5M | $2.1M |
| Change In Fair Value Of Bonus Rights Liability | -$55.6K | $18.7K | $75.8K | |
| Other Liabilities Noncurrent | $47.2K | $102.8K | $84.1K | |
| Retained Earnings Accumulated Deficit | -$97.1M | -$76.4M | -$61.6M | |
| Property Plant And Equipment Net | $328.5K | $27.1K | $1.7K | |
| Prepaid Expense And Other Assets Current | $3.5M | $1.1M | $366.3K | |
| Liabilities Current | $9.1M | $3.4M | $2.6M | |
| Liabilities And Stockholders Equity | $79.7M | $50.7M | $2.5M | |
| Liabilities | $17.2M | $11.6M | $7.2M | |
| Common Stock Value | $133.9M | $99.1M | $39.8M | |
| Cash And Cash Equivalents At Carrying Value | $66.0M | $48.5M | $1.4M | |
| Assets | $79.7M | $50.7M | $2.5M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$104.3K | -$104.3K | -$104.3K | |
| Accounts Payable And Accrued Liabilities Current | $9.0M | $2.4M | $1.4M | |
| Restricted Cash Current | $58.4K | $17.9K | $90.4K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $47.1M | -$589.1K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $48.6M | $1.5M | ||
| Assets Current | $79.0M | $50.3M | $1.9M | |
| Intangible Assets Net Excluding Goodwill | $532.0K | |||
| Preferred Stock Value | $62.00 | $62.00 | $62.00 | |
| Deposit Assets | $48.5M | $1.4M | ||
| Deferred Income Current | $153.2K | $10.4K | ||
| Reversal Of Accrued Interest Income Related Party | -$2.6K | $2.6K | ||
| Reclassification Of Derivative Liability For Warrants Repriced From CAD To USD Exercise Price | $4.3M | $4.0M | ||
| Other Assets Noncurrent | $45.7K | |||
| Provision For Loan Lease And Other Losses | $55.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $33.9M | $31.9M | $40.8M | -$2.6M | $1.0M | $535.2K | -$6.2M | -$579.4K | $1.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $35.5M | $39.5M | $45.6M | $3.8M | $1.2M | $2.4M | $908.4K | $1.2M | ||
| Change In Fair Value Of Bonus Rights Liability | $11.2K | -$84.1K | ||||||||
| Other Liabilities Noncurrent | $152.2K | $187.9K | $114.0K | $74.3K | $46.8K | |||||
| Retained Earnings Accumulated Deficit | -$90.1M | -$88.8M | -$78.3M | -$70.6M | -$68.8M | |||||
| Property Plant And Equipment Net | $202.8K | $72.5K | $70.5K | $1.0K | $1.2K | |||||
| Prepaid Expense And Other Assets Current | $2.9M | $2.5M | $1.2M | $740.9K | $319.8K | |||||
| Liabilities Current | $6.8M | $3.0M | $2.8M | $3.0M | $1.6M | |||||
| Liabilities And Stockholders Equity | $46.3M | $45.1M | $48.6M | $5.0M | $2.1M | |||||
| Liabilities | $12.4M | $13.2M | $7.8M | $7.9M | $3.5M | |||||
| Common Stock Value | $101.8M | $99.2M | $99.1M | $49.1M | $49.0M | |||||
| Cash And Cash Equivalents At Carrying Value | $35.4M | $39.4M | $45.5M | $3.7M | $1.0M | |||||
| Assets | $46.3M | $45.1M | $48.6M | $5.0M | $2.1M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$104.3K | -$104.3K | -$104.3K | -$104.3K | -$104.3K | |||||
| Accounts Payable And Accrued Liabilities Current | $6.5M | $2.8M | $2.6M | $1.7M | $1.2M | |||||
| Restricted Cash Current | $58.4K | $58.4K | $95.0K | $107.0K | $175.3K | $163.7K | $201.5K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $3.8M | $1.2M | $908.4K | $1.2M | ||||||
| Assets Current | $45.7M | $44.6M | $48.1M | $4.5M | $1.5M | |||||
| Intangible Assets Net Excluding Goodwill | $407.6K | $413.0K | $432.7K | $452.5K | ||||||
| Preferred Stock Value | $62.00 | $62.00 | $62.00 | $62.00 | $62.00 | |||||
| Deposit Assets | $39.4M | $45.5M | $3.7M | $1.0M | $852.3K | $706.9K | $1.2M | |||
| Deferred Income Current | $301.2K | $231.8K | $239.5K | $50.8K | $28.9K | |||||
| Reversal Of Accrued Interest Income Related Party | -$2.6K | |||||||||
| Reclassification Of Derivative Liability For Warrants Repriced From CAD To USD Exercise Price | $3.9M | |||||||||
| Other Assets Noncurrent | $11.4K | $80.0K | $114.3K | |||||||
| Provision For Loan Lease And Other Losses | $55.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | |||
| Share Based Compensation | $4.9M | $1.1M | $2.4M |
| Net Cash Provided By Used In Operating Activities | -$20.4M | -$7.8M | -$8.8M |
| Net Cash Provided By Used In Financing Activities | $38.2M | $54.9M | $8.2M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.5M | $671.7K | $117.3K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $6.5M | $1.0M | -$1.5M |
| Proceeds From Stock Options Exercised | $364.6K | $1.8K | $27.0K |
| Proceeds From Issuance Of Common Stock | $3.7M | $9.2M | |
| Payments Of Stock Issuance Costs | $2.5M | $5.7M | $1.1M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$19.6K | ||
| Proceeds From Issuance Of Warrants | $5.9M | $300.0K | |
| Payments To Acquire Property Plant And Equipment | $293.5K | $26.7K | |
| Net Cash Provided By Used In Investing Activities | -$293.5K | -$26.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q1 2025 | Q2 2024 | Q1 2024 | Q2 2023 |
|---|---|---|---|---|---|
| Stock Issued During Period Value Share Based Compensation | $375.3K | $963.3K | |||
| Share Based Compensation | $1.4M | $348.1K | |||
| Net Cash Provided By Used In Operating Activities | -$2.0M | -$2.5M | |||
| Net Cash Provided By Used In Financing Activities | -$834.3K | $3.4M | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $164.0K | $213.4K | |||
| Increase Decrease In Accounts Payable And Accrued Liabilities | $128.6K | -$503.7K | |||
| Proceeds From Stock Options Exercised | |||||
| Proceeds From Issuance Of Common Stock | $923.2K | $3.7M | |||
| Payments Of Stock Issuance Costs | $405.8K | ||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | |||||
| Proceeds From Issuance Of Warrants | |||||
| Payments To Acquire Property Plant And Equipment | $63.3K | ||||
| Net Cash Provided By Used In Investing Activities | -$63.3K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 17.7M | 7.2M | 3.6M |
| Earnings Per Share Diluted | $-1.18 | $-2.04 | $-3.84 |
| Earnings Per Share Basic | $-1.17 | $-2.04 | $-3.84 |
| Weighted Average Number Of Diluted Shares Outstanding | 17.7M | 7.2M | 3.6M |
| Common Stock Shares Issued | 21.7M | 16.0M | 4.7M |
| Common Stock Shares Outstanding | 21.7M | 16.0M | 4.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 16.1M | 16.0M | 16.0M | 6.0M | 6.0M | 5.7M | 3.9M | 94.6M |
| Earnings Per Share Diluted | $-0.30 | $-0.65 | $-0.13 | $-0.31 | $-0.35 | $-0.87 | $-0.84 | $-0.03 |
| Earnings Per Share Basic | $-0.08 | $-0.65 | $-0.13 | $-0.31 | $-0.35 | $-0.87 | $-0.84 | $-0.03 |
| Weighted Average Number Of Diluted Shares Outstanding | 16.0M | 16.0M | 6.0M | 6.0M | 5.7M | 3.9M | 94.6M | |
| Common Stock Shares Issued | 16.3M | 16.0M | 16.0M | 6.0M | 150.5M | |||
| Common Stock Shares Outstanding | 16.3M | 16.0M | 16.0M | 6.0M | 150.5M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Fair Value Adjustment Of Warrants | |||
| Investment Income Interest | $161.7K | $6.8K | |
| Foreign Currency Transaction Gain Loss Before Tax | -$37.6K | $9.9K | |
| Stock Issued During Period Value Stock Options Exercised | $707.9K | $1.8K | $27.0K |
| Interest Paid Net | $4.9K | $37.8K | $59.8K |
| Depreciation And Amortization | $58.6K | $81.2K | $84.5K |
| Stock Issued During Period Value New Issues | $32.1M | $52.8M | |
| Stock Issued During Period Value Other | $3.7M | $9.2M | |
| Reallocation Of Fair Value Of Share Options Upon Exercise | $410.6K | $126.8K | $1.4M |
| Additional Paid In Capital | $25.8M | $16.5M | $17.3M |
| Warrants And Rights Outstanding | $4.5M | ||
| Stock Issued During Period Value Warrants Exercised | $1.9M | $300.0K | |
| Stock Issued1 | $928.9K | $618.0K | |
| Government Assistance Operating Expense | -$53.1K | $17.5K | $80.0K |
| Amounts Paid From Restricted Government Grant Funds | $134.1K | $446.4K | $111.1K |
| Proceeds Received From Restricted Government Grant | $174.7K | $373.8K | $201.5K |
| Adjustments To Additional Paid In Capital Warrant Issued | $5.6M | ||
| Stock Issued During Period Value Issued For Services | $2.3M | ||
| Issuance Of Stock And Warrants For Services Or Claims | $2.3M | ||
| Translation Adjustment Functional To Reporting Currency Increase Decrease Gross Of Tax | -$4.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Fair Value Adjustment Of Warrants | -$3.7M | $5.2M | -$591.7K | -$187.1K | $515.8K | $71.9K | |||
| Investment Income Interest | $425.0K | $470.7K | $1.9K | $2.2K | $12.1K | $2.7K | $2.2K | ||
| Foreign Currency Transaction Gain Loss Before Tax | -$5.5K | -$957.00 | -$8.2K | -$6.9K | -$14.6K | -$13.3K | -$18.3K | ||
| Stock Issued During Period Value Stock Options Exercised | $364.6K | $1.8K | $10.5K | ||||||
| Interest Paid Net | $4.9K | $16.6K | |||||||
| Depreciation And Amortization | $7.3K | $20.8K | |||||||
| Stock Issued During Period Value New Issues | -$186.1K | ||||||||
| Stock Issued During Period Value Other | $3.7M | $1.3M | |||||||
| Reallocation Of Fair Value Of Share Options Upon Exercise | $36.8K | ||||||||
| Additional Paid In Capital | $22.3M | $21.6M | $20.1M | $18.7M | $18.5M | ||||
| Warrants And Rights Outstanding | $5.3M | $9.8M | $4.7M | $5.8M | $2.4M | $946.1K | |||
| Stock Issued During Period Value Warrants Exercised | $1.9M | $25.8K | $140.0K | $160.0K | |||||
| Stock Issued1 | $928.9K | ||||||||
| Government Assistance Operating Expense | -$26.4K | $27.0K | |||||||
| Amounts Paid From Restricted Government Grant Funds | $97.5K | $106.7K | |||||||
| Proceeds Received From Restricted Government Grant | $174.7K | $180.0K | |||||||
| Adjustments To Additional Paid In Capital Warrant Issued | |||||||||
| Stock Issued During Period Value Issued For Services | $2.3M | ||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $2.3M | ||||||||
| Translation Adjustment Functional To Reporting Currency Increase Decrease Gross Of Tax | -$4.2M |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.